Amrize Ltd AMRZ
38.22
0.99
2.66%
as of 25 Sep
- Market cap
- $20.5B
- P/E
- 17.5×
Follow AMRZ
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+6 more quarters Free account |
18.59 | 25.12 | 26.68 | 24.34 |
P/S ratio |
2.16 | 2.53 | 2.60 | 2.42 | |
P/FCF ratio |
18.19 | 20.47 | 22.74 | 21.73 | |
P/Operating CF |
31.77 | 16.58 | (34.59) | 69.95 | |
P/B ratio |
2.08 | 2.28 | 2.37 | 2.29 | |
Price to Tangible BV |
12.53 | 12.73 | 13.39 | 13.81 | |
EV/Sales |
2.56 | 2.82 | 3.02 | 2.85 | |
EV/EBITDA |
10.23 | 11.79 | 12.96 | 12.14 | |
EV/Operating CF |
14.94 | 15.06 | 16.58 | 15.97 | |
EV/FCF |
21.56 | 22.76 | 26.37 | 25.63 | |
Quick Ratio |
0.91 | 1.05 | 0.80 | 0.67 | |
Current Ratio |
1.45 | 1.60 | 1.40 | 1.10 | |
Net Debt/EBITDA |
4.99 | 4.54 | 31.92 | 5.45 | |
Debt/Assets |
24.18% | 21.76% | 24.91% | 24.40% | |
Debt/Equity |
0.45 | 0.40 | 0.46 | 0.47 | |
Asset Turnover |
1.03 | 0.98 | 0.98 | 0.50 | |
Operating CF/Net income |
1.55 | 5.82 | 7.72 | 0.88 | |
Capex/Depreciation |
(0.67) | (0.61) | (1.13) | (0.98) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.49% | 10.24% | 13.41% | 8.10% | |
Intangible Assets out of Total Assets |
0.45 | 0.45 | 0.44 | 0.44 | |
Share Based Compensation of Revenue |
0.08% | 0.28% | 0.41% | 0.31% | |
Graham Net Nets |
(0.24) | (0.22) | (0.22) | (0.24) | |
Graham Number |
37.01 | 33.90 | 33.43 | 33.86 | |
Earnings Yield |
5.38% | 3.98% | 3.75% | 4.11% | |
Free Cash Flow Yield |
5.50% | 4.88% | 4.40% | 4.60% | |
Revenue per Share |
6.64 | 5.14 | 3.94 | 6.32 | |
Operating CF per Share |
1.53 | 3.26 | (1.62) | 0.76 | |
Capex per Share |
(0.27) | (0.27) | (0.48) | (0.46) | |
Free Cash Flow per Share |
1.25 | 2.99 | (2.10) | 0.30 | |
Cash per Share |
1.49 | 3.48 | 1.99 | 1.32 | |
Shareholders Equity per Share |
23.32 | 23.72 | 23.66 | 23.27 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
23.32 | 23.72 | 23.66 | 23.27 | |
Free Cash Flow |
694.00 | 1,656.00 | (1,163.00) | 168.00 | |
Working Capital |
1,417.00 | 1,728.00 | 1,230.00 | 430.00 | |
Capital Expenditures |
(151.00) | (148.00) | (267.00) | (253.00) | |
Net Current Asset Value |
(6,568.00) | (6,475.00) | (6,897.00) | (7,161.00) | |
EV/EBIT |
14.38 | 17.45 | 19.51 | 18.30 | |
Capex to Sales |
0.04 | 0.05 | 0.12 | 0.07 | |
Net Profit Margin |
14.83% | 10.91% | (5.33%) | 13.68% | |
Price to Operating Income |
12.13 | 15.69 | 16.82 | 15.52 | |
| Other line items | |||||
Average Receivables |
— | 1,255.50 | 1,479.50 | 1,974.50 | |
Average Payables |
— | 1,389.00 | 1,153.00 | 1,351.00 | |
Average Inventory |
— | 1,398.50 | 1,509.50 | 1,597.00 | |
Average Assets |
12,017.50 | 12,104.50 | 12,134.50 | 24,192.50 | |
Average Common Equity |
— | 11,162.00 | 11,501.00 | 12,645.50 |
Columns are period end dates